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iNTRoDuCTioN
Maternal mortality associated with anaesthesia 
becomes substantially reduced (around 80%) when 
general anaesthesia is not used for caesarean sec-
tions according to studies published in the USA and 
the UK at the end of the 1970s and 1980s.1,2 The 
possible risks and complications associated with the 
Managing hypotension induced by spinal 
anesthesia for caesarean section
general technique for a caesarean section include de-
finitive management of the airway route, respiratory 
assistance or failed intubation, bronchoaspiration of 
gastric content, oral, pharyngeal or laryngeal trau-
ma, postoperative nausea and vomiting, retarded 
lactation and sedation of the neonate.1,3
The mother and her child can share the birth 
with all the accompanying emotional implications 
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deriving from this if regional anaesthesia is used. 
The need for using systemic opiates during the 
postoperative period becomes reduced and the risks 
described for the general technique are avoided.
The advantages of using spinal anaesthesia in-
clude the technique’s simplicity, its action’s rapid 
initiation, the low failure rate, the use of  minimum 
drug volume and concentration, an important move 
away from applying a systemic toxic dose and there 
is suitable muscular relaxation during surgery.1,4 
The foregoing reasons make this the method of 
choice for most elective caesarean sections and a 
large percentage of emergency caesareans when an 
expectant mother does not have an epidural catheter 
functioning or does not present a contraindication 
for neuroaxial techniques.5
Hypotension is a frequently occurring adverse 
effect in the obstetric population to which neuraxis 
anaesthesia or analgesia is to be administered.1,5,6 
it occurs more frequently in patients requiring 
anaesthesia for surgical procedures than in patients 
receiving neuraxis analgesia during labour due to 
the need for denser and more extensive blocks in 
the former group.5,6 Haemodynamic changes oc-
cur abruptly with spinal anaesthesia compared to 
the epidural technique, thereby leading to clinical 
manifestations and maternal-foetal complications 
associated with hypotension frequently happen with 
subarachnoideal anaesthesia.5 
DEFiNiTioN
Even though there is variability in defining hypo-
tension for expectant mothers involving neuroaxial 
anaesthesia, most authors define it as being a 20% 
to 30% reduction in systolic blood pressure, compa-
ring it to initial values (prior to drugs being placed 
in the neuraxis) or absolute systolic blood pressure 
values between 100 mmHg and 90 mmHg.2,3,4 
It must be born in mind that blood pressure (the 
same as other haemodynamic and physiological 
variables) is constantly changing and adapts to di-
fferent phenomena affecting homeostasis; it must 
be interpreted within a suitable clinical context, 
meaning that placing cut-offs points for operatio-
nalising the definition of hypotension may only 
provide a guide and is not suitable for intensifying 
a definition which (as explained above) has many 
versions and variability.
As one is dealing with measurement, there may 
be variability explained by random or systematic 
errors inherent in the measurement method (direct 
or indirect) and individual variability (i.e. of a patient 
at different moments) which must be born in mind 
when interpreting isolated blood pressure figures
mECHANiSmS ExPlAiNiNg mATERNAl 
HyPoTENSioN 
It is expected that T4 sensory level will be reached 
when the suba rachnoid anaesthesia technique is 
used for a caesarean section, thereby providing a 
comfortable intra-operative period for the patient 
and gynaecologist, reducing the risk of conversion to 
general anaesthesia, the use of parenteral medica-
tion and patient dissatisfaction with the anaesthetic 
technique.6 This explains why it is practically inevi-
table that a patient presents total pharmacological 
sympathectomy. 
Spinal anaesthesia-induced hypotension for 
caesarean section is triggered by many factors, 
including: 
The sympatectomy explains reduced peripheral • 
vascular resistance, venous return and cardiac 
output, which could be reduced by low venous 
return and bradycardia (extensive blocks);
Aortocaval compression caused by mechani-• 
cal phenomena of the pregnant uterus during 
the last trimester of pregnancy when a patient 
adopts a supine position;4,6 and
Normal expectant mothers also present an auto-• 
nomic imbalance explaining relative sympathetic 
hyperactivity making them more susceptible to 
hypotension due to neuroaxial block. 
It should not be forgotten that these patients are, 
occasionally, submitted to very prolonged periods 
of fasting.
Frequency 
The frequency of giving birth by caesarean sec-
tion depends on each country’s cultural, social and 
economic factors, personal beliefs and available 
resources. This may be as high as 55% in South-
America7 or as low as 15.5% in England.8,14 Accor-
ding to an ecological study carried out in Colombia, 
the national frequency for giving birth by caesarean 
section is 16.8%; there is a substantial difference 
when comparing this frequency for public hospitals 
and social security system ones with private hospi-
tals, 32.5% and 58.6% prevalence being reported, 
respectively.9
More than 90% of caesarean sections are ca-
rried out under regional anaesthesia in developed 
countries, spinal anaesthesia being used in elective 
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caesarean sections and emergencies in more than 
80% and more than 40% of cases, res pectively.1
There is a 33% incidence of hypotension caused by 
spinal block in the general population (non-expectant 
mothers). This is greater than 90% in pregnant fema-
les (depending on the definition used) making this the 
most frequently occurring adverse effect caused by 
the intervention described to date. Multiple pregnan-
cies are not considered to be a risk fac tor for hypo-
tension caused by spinal anaesthesia for caesarean 
section compared to single pregnancies.6
maternal effects 
Even though maternal hypotension is presented 
in most females where spinal anaesthesia is used for 
caesarean section, the probable clinical implications 
arising from this phenomenon are not clear; howe-
ver, patients may present uncomfortable symptoms 
such as nausea, vomiting and dizziness. If hypoten-
sion is sustained and is not suitably treated, it can 
lead to serious adverse effects for the mother, such 
as loss of consciousness, apnoea, bronchoaspira-
tion of gastric content, aspiration pneumonia and 
cardiorespiratory arrest.4,6
Foetal effects
Uteroplacentary blood flow depends di rectly 
on maternal blood pressure.10,11 The clinical com-
promise associated with sustained different levels 
of hypotension is also not clear for the foetus.10,6 
Several animal models have suggested greater 
foetal compromise related to profound, sustained 
hypotension.11 
Slight hypotension is associated with hypoxemia 
and foetal acidosis; if such conditions are maintai-
ned, then this could trigger off profound neurological 
compromise and foetal death.10,11
TREATmENT 
Prophylaxis
It seems reasonable to think that by preventing 
maternal hypotension then the frequency and se-
verity of the probable maternal-foetal consequences 
described will become reduced. Many ploys and 
treatments are currently being used for preven-
ting spinal block-associated hypotension such as 
a patient’s suitable position with displacement 
of the pregnant uterus for avoiding aortocaval 
compression12,13, using endovenous crystalloid 
and colloid liquids for increasing available vascu-
lar volume14,15, using ephedrine for raising heart-
beat rate, cardiac output and peripheral vascular 
resistance16,17,18, using alpha 1 agonists for increa-
sing peripheral vascular resistance and mechanical 
compression of the lower limbs for increasing venous 
return.6
Administering intravenous liquids is a frequent 
practice during caesarean section, before or after 
placing the spinal block.14,19,20 Administering crysta-
lloids or colloids depends on local availability, cost 
(crystalloids are generally cheaper) and the balance 
between possible risks and benefits.14,21 
Colloids generally have infrequently occurring 
but potentially serious adverse effects, such as ana-
phylactic reactions, renal failure, coagulopathy, the 
transmission of diseases such as hepatitis C with 
the use of human albumin and bovine spongiform 
encephalopathy with the use of bovine-derived 
pharmaceutical preparations such as gelatine hae-
maccel.19 
Vasoconstrictor agents are not innocuous and 
the controver sy regarding which of them to use pro-
phylactically also extends to managing established 
hypotension.16 
The conclusions drawn in the metanalysis by 
Cyna et al.,22 concerning techniques for preventing 
hypotension during spinal anaesthesia for caesa-
rean section are given below. 
75 assays were included (4,624 females). Crysta-
lloids were more effective than any type of therapy 
involving endovenous liquids ( relative risk [RR] 0.78; 
95%: confidence interval [95%CI] 0.60 to 1.00) and 
colloids were more effective than crystalloids (RR 
0.68; 95%CI: 0.52 to 0.89; 11 assays; 698 females) 
for preventing hypotension following spinal anaes-
thesia for caesarean section. Differences were not 
detected for the different doses, infusion speeds or 
methods for administering colloids or crystalloids.
Ephedrine was significantly more effective for 
preventing hypotension than passive control (RR 
0.51; 95%CI: 0.33 to 0.78; seven assays; 470 fe-
males) or crystalloids (RR 0.70; 95%CI: 0.50 to 
0.96; four assays; 293 females). No significant 
differences were observed between ephedrine and 
phenylephrine regarding hypotension (RR 0.95; 
95%CI: 0.37 to 2.44; three assays; 97 females) and 
phenylephrine was more effective than the controls 
(RR 0.27; 95%CI: 0.16 to 0.45; two assays; 110 
females). Infusion speed or high ephedrine doses 
could increase the incidence of high blood pressure 
and tachycardia. 
Compressing the lower limbs was more effective 
for preventing hypotension than no compression 
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(RR 0.69; 95%CI: 0.53 to 0.90; seven assays; 399 
females), even though the effectiveness of different 
compression methods seems to be variable. Com-
paring action regarding different physical methods, 
such as position, were also not seen to be effective; 
however, such assays were frequently small and 
had little power for detecting true effects (if indeed 
they did exist). 
Reducing the local anaesthetic dose used in 
spinal anaesthesia could reduce the incidence and 
severity of maternal hypotension caused by subara-
chnoideal anaesthesia. Clinical experiments which 
have been published comparing fixed and weight-
adjusted spinal dose have thus found clinically 
significant (20% difference between groups) and 
statistically significant lower hypotension frequency 
on adjusting a dose for weight.23 
Treating hypotension 
In spite of using all the prophylactic measu-
res described, some being effective for preventing 
hypotension such as using crystalloids, colloids, 
ephedrine, phenylephrine and compressing the 
lower limbs, none of these prophylactic interventions 
can totally avoid treating maternal hypotension be-
coming established during caesarean section with 
spinal anaesthesia. Thus,40% to 60% of patients will 
continue being treated with vasoconstrictor agents 
in the context described above.6
Phenylephrine and ephedrine are the vasocons-
trictor agents which are currently being recom-
mended and used for controlling hypotension6; the 
phenylephrine: ephedrine potency ratio is taken as 
being  80:1.16,17 An ideal vasoconstrictor agent must 
have a short latency period and duration, favourably 
affect foetal heart rate, preserve uteroplacentary 
perfusion and be economic and easily obtained.18 
Ephedrine. Ephedrine was the vasoconstrictor 
agent of choice in obstetric anaesthesia for many 
years due to its favourable pharmacodynamic 
profile; many animal models have demonstrated a 
marked increase in uteroplacentary blood flow.6,24
This medicament has a dual effect (direct and 
indirect). It is a direct agonist for adrenergic alpha 
and beta receptors and stimulates norepinephrine 
release from adrenergic binding. It mainly acts in-
directly (norepinephrine release).6,16
Favourable effects on utero placentary circula-
tion can be explained by an increase in nitric oxide 
synthase and reduced sympathetic innervation of 
the vascular uterine layer. Ephedrine also presents 
beta 1 adrenergic action, thereby explaining positive 
chronotropism, inotropism and chromotropism, the-
reby substantially increasing heart rate and cardiac 
load and exercising a modest effect on adrenergic 
beta 2 receptors. This may partly explain utero-
placentary vasculature dilatation. Its vasopressor 
action (arterial and venous) is mediated by alpha 
1 action.18
Ephedrine is excreted in urine without being 
metabo lised and its action is ended due to pre-
synaptic recapture in adrenergic binding, thereby 
making its pharmacokinetic profile (beginning of 
action and prolonged duration) not very favoura-
ble and thus might partly explain its therapeutic 
failures because it presents its vasopressor and 
sympathicomimetic action at different moments 
during episodes of hypotension.24,6 
Studies have been carried out for determining 
the ideal do se presenting suitable effectiveness for 
treating hypotension and presenting fewer adverse 
effects. Studies have been carried out for determining 
the ideal do se for treating hypotension with fewer 
adverse effects. It has been determined that the ideal 
dose should be greater than 12 mg by contrast with 
that recommended by most texts (10 mg).25,6
Ephedrine increases myocardial demand and 
consumption of oxygen. It also increases the amount 
of circulating catecholamines thereby making the 
myocardial and ventricular conduction system more 
susceptible to cardiac arrythmia.25 
Many studies have related ephedrine use to foetal 
acidosis; the action mechanism so implicated is an 
increase in foetal catecholamines thereby increasing 
metabolism, mainly in foetal brown fat, and increa-
sing foetal carbon dioxide production. In spite of 
this, foetal clinical adverse effects caused by reduced 
foetal pH have not been demonstrated.25 
Phenylephrine. Phenylephrine is a synthetic sym-
pathicomimetic agent acting as a short latency and 
duration vasoconstrictor due to it being metabolised 
by catechol-O-methyltransferase and monoami-
nooxidase. It acts on adrenergic alpha 1 receptors 
mediating vasoconstriction.24,6 Sympathectomy-
mediated hypotension is mainly due to vasodilata-
tion with reduced peripheral vascular resistance, an 
effect clearly antagonised by phenylephrine.6 
It increases venous return and preload, in turn 
mediating negative chronotropism; there is also an 
increase in systolic, diastolic and medium blood 
pressure, explaining bradycardia reflex and, in turn, 
explaining its protection-inducing profile against 
arrythmias compared to ephedrine6 
Other alpha 1 agonists were initially investigated 
for managing pharmacological sympathectomy-me-
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diated hypotension (like metoxamine); however, va-
soconstriction of the uteroplacentary vascular layer 
was presented in animal models, thereby hampering 
their early development within the pertinent the-
rapeutic arsenal.16,17 However, phenylephrine was 
introduced as vasoconstrictor agent to be applied 
whilst giving birth due to ephedrine’s therapeutic 
failures (many being explained by inadequate qua-
lification and administration time).18
It has been shown that phenylephrine has an 
uteroplacentary layer vasoconstrictor effect; howe-
ver, this effect does not result in foetal clinical 
complications or paraclinical changes (acid-base 
imbalance) in umbilical arterial blood. On the con-
trary, it has better safety as foetal physiological pH 
is maintained.6
Several clinical studies have concentrated on 
phenylephrine, supporting its use in obstetric 
anaesthesia; however, it should be stressed that no 
clinical evidence is available regarding emergency 
situations such as unsatisfactory foetal state, pre-
mature foetus or mothers suffering from high blood 
pressure.6 
Ethylephrine. Few clinical studies have evaluated 
this drug’s effectiveness and safety for the clinical 
indication in question. This medicament is easily 
obtained in our setting and its clinical effects may 
be extrapolated to other alpha 1 agonists, such as 
phenylephrine.
Other vasoconstrictor agents and forms of adminis-
tration. Metaraminol, metoxamine and angiotensin 
II are other vasoconstrictor agents which are used 
in clinical practice; fewer clinical trials have been 
carried out on them and they have few advantages 
regarding their effectiveness and safety compared 
to ephedrine or phenylephrine.6 
Methodologically supported benefits for the 
indication in question have not been shown when 
administering vasopressor infusions or combined 
therapy.2,6 
PATiENTS SuFFERiNg FRom 
HyPERTENSivE DiSoRDERS DuRiNg 
PREgNANCy
Patients presenting hypertensive disorders during 
pregnancy (especially preeclampsia) have increased 
vascular tone due to endo thelial changes, partly 
because of increased sympathetic influx, thereby 
making them more prone to hypotension from phar-
macological sympathectomy than healthy pregnant 
females. However, some studies have shown that 
spinal anaesthesia-induced hypotension in patients 
with preeclampsia is less frequent and less severe, 
possibly due to planetary alterations and growth 
restriction being presented.26,6 
Little research has been aimed at identifying the 
vasoconstrictor agent and dose of choice in this 
group of patients; however, publications concerning 
severe preeclamp tics have used a 3 to 6 mg dose of 
ephedrine with suitable outcomes. Many authors 
recommend reducing vasopressor dose for preven-
ting the risk of high blood pressure associated with 
its use.6 
iNvESTigATioN
Studies are currently being carried out for de-
termining genetic polymorphism in adrenergic 
receptors, explaining individual susceptibility to 
hypotension during pharmacological sympathec-
tomy and response to vasoconstrictor agents. Fur-
thermore, one hypothesis proposes that analysing 
heart rate variability is directly related to individual 
sympathetic activity and indirectly so to the risk 
of hypotension or responding to vasoconstrictor 
agents.6 
REFERENCiAS
1. Ng K, Parsons J, Cyna AM, Middleton P. Anestesia raquídea 
versus epidural para la cesárea. Biblioteca Cochrane Plus 
2008.
2. Mercier FJ, Bonnet MP, De la Dorie A, Moufouki M, Banu 
F, Hanaf A et al. Spinal anaesthesia for caesarean section: 
fluid loading, vasopressors and hypotension. Ann Fr Anesth 
Rean. 2007; (26): 688-93.
3. Macarthur A. Solving the problem of spinal-induced hypo-
tension in obstetric anesthesia. Can J Anesth. 2002; (49): 
536-9.
4. Burns SM, Cowan CM, Wilkes RG. Prevention and manage-
ment of hypotension during spinal anaesthesia for elective 
Caesarean section: a survey of practice. Anaesthesia. 2001; 
(56):777-98.
5. Simmons SW, Cyna AM, Dennis AT, Hughes D. Analgesia 
espinal y epidural combinadas versus analgesia epidural en 
el trabajo de parto. Biblioteca Cochrane Plus 2008.
6. Reidy J, Douglas J. Vasopressors in obstetrics. Anesthesiol 
Clin. 2008; (26): 75-88.
140
Rev. Col. Anest. Mayo-Julio 2009. Vol. 37- No. 2: 131-140
Managing hypotension induced by spinal anesthesia for caesarean section- Montoya BH., Oliveros C.I., Moreno DA.
7. Behague DP, Victora CG, Barros FC. Consumer demand for 
caesarean sections in Brazil: informed decision making, pa-
tient choice, or social inequality? A population based cohort 
study linking ethnographic and epidemiological methods. 
BMJ. 2002;324:942. 
8. Chamberlain G, Steer P. ABC of labour care: operative deli-
very. BMJ 1999;318(7193):1260-4.
9. Belizán JM, Althabe F, Barros FC, Alexander S. Rates and 
implications of Caesarean section in Latin America: Ecolo-
gical study. BMJ. 1999; (319): 1.397-1400.
10. Valli J, Pirhonen J, Aantaa R, Erkkola R, Kanto J. The effects 
of regional anaesthesia for caesarean section on maternal 
and fetal blood flow velocities measured by Doppler Ultra-
sound. Acta Anaesthesiol Scand. 1994; (38): 165-9.
11. Ngan WD, Lee A. Multivariate analysis of factors associated 
with umbilical arterial pH and standard base excess after 
Caesarean section under spinal anaesthesia. Anaesthesia. 
2003; (58):125-30.
12. Kundra P, Khanna S, Habeebullah S, Ravishankar M. Ma-
nual displacement of the uterus during Caesarean section. 
Anaesthesia. 2007;(62):460-5.
13. Kundra P, Kahana S, Habeebullah S, Ravishankar M. Ma-
nual displacement of the uterus during Caesarean section. 
Anaesthesia. 2007; (62): 460-5.
14. Hofmeyr GJ, Cyna AM, Middleton P. Precarga profiláctica 
por vía intravenosa para la analgesia regional durante el 
trabajo de parto. Biblioteca Cochrane Plus 2008. 
15. Chanimov M, Gershfeld S, Cohen ML, Sherman D, Bahar M. 
Fluid preload before spinal anaesthesia in Caesarean section: 
the effect on neonatal acid-base status. Eur J Anesthesiol. 
2006; (23): 676-9.
16. Saravanan S, Kocarev M, Wilson RC, Watkins E, Columb MO, 
Lyons G. Equivalent dose of ephedrine and phenylephrine 
in the prevention of post-spinal hypotension in Caesarean 
section. Br J Anaesth. 2006; (96): 95-9.
17. Riley ET. Spinal anaesthesia for Caesarean delivery: keep 
the pressure up and don’t spare the vasoconstrictors. Br J 
Anaesth. 2004 May;92(5):782. 
18. Cooper DW, Mowbray P. Ephedrine or phenylephrine to 
prevent or treat hypotension during spinal anaesthesia for 
caesarean section. Int J Obst Anesth. 2004; (8):197-8.
19. Perel P, Roberts I. Coloides versus cristaloides para la reani-
mación con líquidos en pacientes en estado crítico. Biblioteca 
Cochrane Plus 2008
20. Ngan WD, Khaw KS, Lee BB, Ng FF, Wong MS. Randomized 
controlled study of colloid preload before spinal anaesthesia 
for Caesarean section. Br J Anaesth. 2001; (87):772-4.
21. Siddik SM, Aouad MT, Kay GE, Sfeir MM, Baraka AS. Hi-
droxyethylstarch 10% is superior to Ringer‘s solution for 
preloading before spinal anesthesia for Cesarean section. 
Can J Anesth. 2000; (47):616-21.
22. Cyna AM, Andrew M, Emmett RS, Middleton P, Simmons 
SW. Técnicas para la prevención de la hipotensión durante 
la anestesia espinal para la cesárea. Biblioteca Cochrane 
Plus. 2008.
23. Harten JM, Boyne I, Hannah P, Varveris D, Brown A. Effects 
of a height and weight adjusted dose of local anaesthetic for 
spinal anaesthesia for elective Caesarean section. Anaesthe-
sia. 2005; (60): 348-53.
24. Lee A, Warwick D, Ngan WD, Gin T. A quantitative, systema-
tic review of randomized controlled trials of ephedrine versus 
phenylephrine for the management of hypotension during 
spinal anesthesia for cesarean delivery. Anesth Analg. 2002; 
(94):220-6.
25. Kluger MT. Ephedrine may predispose to arrhythmias 
in obstetric anaesthesia. Anaesth Intensive Care. 2000; 
(28):336.
26. Aya A, Vialles N, Tanoubi I, Mangin R, Ferrer JM, Robert C, 
et al. Spinal anesthesia-induced hypotension: a risk compa-
rison between patients with severe preeclampsia and healthy 
women undergoing preterm Cesarean delivery. Anesth Analg. 
2005; 101: (869-75).
